EGFL7 antibody (AA 30-80)
Quick Overview for EGFL7 antibody (AA 30-80) (ABIN733988)
Target
See all EGFL7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 30-80
-
Predicted Reactivity
- Human,Mouse,Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from mouse EGFL7
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:100-1000
IHC-P 1:100-500
IF(IHC-P) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
-
: "VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network." in: International journal of clinical and experimental pathology, Vol. 7, Issue 3, pp. 1022-31, (2014) (PubMed).
-
: "VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network." in: International journal of clinical and experimental pathology, Vol. 7, Issue 3, pp. 1022-31, (2014) (PubMed).
-
- EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
-
Alternative Name
- Egfl7
-
Background
-
Synonyms: Zneu1, VE-statin, Epidermal growth factor-like protein 7, EGF-like protein 7, Multiple epidermal growth factor-like domains protein 7, Multiple EGF-like domains protein 7, NOTCH4-like protein, Vascular endothelial statin, Egfl7, Megf7
Background: Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cell adhesion to the extracellular matrix and angiogenesis.
-
Gene ID
- 353156
-
UniProt
- Q9QXT5
Target
-